-

 

Women: Impacts of Per- and Polyfluoroalkyl Substances (PFAS) on Fertility in Women

Abstract

Per- and polyfluoroalkyl substances (PFAS) are a class of more than 15,000 synthetic organic chemicals used for over seven decades in industrial and consumer applications due to their resistance to heat, water, and oil. However, their chemical stability has led to persistent environmental contamination, with measurable concentrations detected in human blood, breast milk, and even placental tissues. The implications for women’s reproductive health are profound. This paper provides an expanded overview of PFAS exposure pathways, biological mechanisms of reproductive interference, empirical evidence linking PFAS to infertility and pregnancy loss, and the socio-political urgency of policy intervention. It calls for a multi-sectoral policy approach that integrates regulation, surveillance, research, and public education to protect female fertility and reproductive justice globally.

1. Introduction

Per- and polyfluoroalkyl substances (PFAS) are used in a wide range of commercial products including non-stick cookware (Teflon), waterproof clothing, stain-resistant fabrics, food packaging, firefighting foams, and certain cosmetics. Their carbon-fluorine bonds are among the strongest in organic chemistry, making them exceptionally resistant to degradation. Consequently, PFAS persist in air, soil, water, and biota, earning the nickname “forever chemicals.”

In the last two decades, epidemiological and toxicological studies have raised alarm over PFAS bioaccumulation and its effects on human health. Women, particularly those of reproductive age, represent a critical demographic because reproductive functions—hormonal balance, ovarian activity, and pregnancy viability—are sensitive to endocrine-disrupting chemicals (EDCs). PFAS have been increasingly implicated in delayed conception, menstrual irregularities, early menopause, and reduced success rates in assisted reproductive technologies.

This concern is especially urgent in low- and middle-income countries (LMICs) where PFAS regulations are weak or absent and women are disproportionately exposed through contaminated water systems and imported consumer goods.

2. PFAS Exposure Pathways and Bioaccumulation

PFAS enter the human body through multiple environmental and occupational routes:

  • Drinking water contamination: Groundwater and surface water near industrial sites and airports are common sources.

  • Food consumption: PFAS bioaccumulate in fish, meat, and dairy, and leach from food packaging and non-stick cookware.

  • Inhalation of dust: Treated furniture, carpets, and household materials release PFAS-containing microdusts.

  • Dermal absorption: Cosmetics, lotions, and feminine hygiene products often contain PFAS compounds.

Once absorbed, PFAS bind to serum proteins, circulate through the bloodstream, and concentrate in the liver, kidneys, and reproductive organs. Their long half-lives (up to 8 years for perfluorooctanoic acid [PFOA]) mean that exposure is cumulative and multigenerational.

3. Mechanisms of PFAS-Induced Reproductive Toxicity

The impacts of PFAS on fertility are mediated through several biological mechanisms:

3.1. Endocrine Disruption

PFAS mimic or block natural hormones, particularly estrogen and progesterone. This interference alters the hypothalamic-pituitary-gonadal axis (HPG axis), disrupting menstrual regularity, follicular development, and ovulation. Disrupted hormonal signaling may lead to anovulatory cycles, lower implantation success, and impaired embryo development.

3.2. Ovarian Function and Reserve

Studies have linked PFAS exposure to decreased levels of anti-Müllerian hormone (AMH)—a biomarker of ovarian reserve—and reduced antral follicle counts. Laboratory studies in animal models demonstrate that PFAS impair folliculogenesis, causing premature ovarian aging and reduced fertility potential (Zhou et al., 2023).

3.3. Thyroid Hormone Interference

Thyroid hormones are critical for metabolism, reproductive cycles, and pregnancy maintenance. PFAS disrupt thyroid function by competing with thyroid hormone transport proteins and altering thyroid receptor expression (Lee et al., 2018). Subclinical hypothyroidism caused by PFAS exposure has been associated with decreased fecundability and increased miscarriage risk.

3.4. Placental and Fetal Development

PFAS cross the placental barrier, directly exposing the fetus. They have been found in umbilical cord blood, amniotic fluid, and placental tissue. Prenatal exposure can alter fetal growth, affect placental hormone production, and increase risks of preterm birth and low birth weight (Steenland et al., 2020).

4. Empirical Evidence from Epidemiological Studies

Epidemiological evidence confirms the link between PFAS exposure and reduced fertility outcomes in women:

  • Fei et al. (2009) found that higher serum concentrations of PFOA and PFOS were associated with longer times to achieve pregnancy.

  • Bach et al. (2015) confirmed this in a Danish cohort, reporting that women in the highest PFAS exposure quartile took significantly longer to conceive.

  • Knox et al. (2011) observed earlier onset of menopause in women exposed to elevated PFAS levels, suggesting accelerated reproductive aging.

  • Zhang et al. (2022) reported reduced embryo implantation and pregnancy rates in women undergoing in vitro fertilization (IVF) with elevated PFAS concentrations.

  • Zhou et al. (2023) demonstrated that PFAS exposure reduced ovarian reserve and altered sex hormone levels, reinforcing the mechanistic evidence for endocrine disruption.

Collectively, these studies underscore a consistent and dose-dependent relationship between PFAS exposure and reproductive impairment.

5. Societal and Transgenerational Implications

PFAS-related fertility decline poses broader societal consequences. Decreased fertility affects population growth, labor productivity, and healthcare systems. Beyond immediate fertility impacts, PFAS also have transgenerational effects—exposure in mothers may alter fetal germ cell development, potentially reducing fertility in offspring. This means that PFAS contamination today can compromise the reproductive capacity of future generations.

Moreover, women in marginalized communities are more likely to experience higher PFAS exposure due to proximity to industrial discharges, unsafe waste disposal, and lack of access to clean water. These inequities highlight the intersection between environmental health, gender equity, and reproductive justice.

6. Policy Recommendations

6.1. Regulatory Reform

Governments should adopt comprehensive PFAS regulation frameworks modeled on the European Union’s REACH and the U.S. EPA’s 2023 PFAS Action Plan. Policies must establish enforceable maximum contamination levels (MCLs) for PFAS in drinking water, soil, and consumer goods.

6.2. Phase-Out of PFAS Production

Phasing out PFAS manufacturing and promoting safer, biodegradable alternatives through green chemistry initiatives are essential to break the contamination cycle.

6.3. Water and Food Safety Monitoring

Investments in advanced filtration systems such as granular activated carbon (GAC) and reverse osmosis (RO) technologies should be prioritized in public water treatment plants. Routine monitoring of PFAS in water and food chains must be mandated.

6.4. Biomonitoring and Health Surveillance

National biomonitoring programs targeting women of reproductive age can help assess PFAS exposure levels and trends. Health registries should track fertility outcomes, menstrual disorders, and pregnancy complications linked to PFAS exposure.

6.5. Public Education and Risk Communication

Educational campaigns are needed to raise awareness about PFAS sources, safe consumer alternatives, and exposure reduction practices—such as avoiding non-stick cookware, PFAS-treated textiles, and certain cosmetic brands.

6.6. Global Collaboration

PFAS pollution transcends borders. International cooperation through frameworks like the Stockholm Convention should include PFAS as priority pollutants, ensuring equitable global mitigation and data sharing.

7. Future Research Directions

While the evidence linking PFAS and infertility is strong, more longitudinal, multi-country studies are needed to confirm causality and understand differential susceptibility among populations. Future research should investigate:

  • Genetic variations in PFAS metabolism among women;

  • Interactions between PFAS and other endocrine-disrupting chemicals;

  • Transgenerational epigenetic effects on reproductive health;

  • Cost-effective remediation technologies for PFAS removal in developing regions.

8. Conclusion

PFAS contamination represents a growing global threat to women’s reproductive health. Evidence consistently links PFAS exposure to decreased fecundability, ovarian dysfunction, and hormonal imbalance, with possible consequences extending across generations. The persistence of PFAS in the environment and in human tissues demands urgent policy action grounded in scientific evidence and reproductive justice principles. Governments, industries, and communities must collaborate to restrict PFAS use, monitor exposure, and invest in safer alternatives. Protecting fertility is not just a health priority—it is a matter of gender equity and human sustainability.

References

Bach, C. C., Bech, B. H., Nohr, E. A., Olsen, J., & Henriksen, T. B. (2015). Perfluoroalkyl acids and time to pregnancy: A prospective cohort study. Human Reproduction, 30(3), 580–589.
Fei, C., McLaughlin, J. K., Tarone, R. E., & Olsen, J. (2009). Perfluorinated chemicals and time to pregnancy. Human Reproduction, 24(5), 1200–1205.
Kjeldsen, L. S., & Bonefeld-Jørgensen, E. C. (2013). Perfluorinated compounds affect the function of sex hormone receptors. Environmental Science and Pollution Research, 20(11), 8031–8044.
Knox, S. S., Jackson, T., Frisbee, S. J., Javins, B., Ducatman, A. M., & Steenland, K. (2011). Implications of early menopause in women exposed to perfluorocarbons. Journal of Clinical Endocrinology & Metabolism, 96(6), 1747–1753.
Lee, Y. J., Kim, M. K., Bae, J., & Yang, J. H. (2018). The association between perfluoroalkyl substances exposure and thyroid function in reproductive-aged women. Environmental Research, 167, 437–444.
Lindstrom, A. B., Strynar, M. J., & Libelo, E. L. (2011). Polyfluorinated compounds: Past, present, and future. Environmental Science & Technology, 45(19), 7954–7961.
Steenland, K., Barry, V., & Savitz, D. (2020). Serum perfluorooctanoic acid and birthweight: An updated meta-analysis with bias analysis. Epidemiology, 31(4), 493–498.
Zhang, Y., Wang, S., Zhang, J., & Chen, Y. (2022). PFAS exposure and outcomes of in vitro fertilization: A systematic review. Reproductive Toxicology, 108, 34–45.
Zhou, Y., Xu, L., & Li, M. (2023). Associations of PFAS exposure with ovarian reserve and reproductive hormones in women. Environmental International, 171, 107729.

Comments

Post a Comment

Popular posts from this blog

-
  Impacts of Pit Latrine Waste on Early Puberty in Africa Introduction Across sub-Saharan Africa, pit latrines serve as the primary sanitation infrastructure for over 50% of urban populations and an even higher proportion in rural areas, providing a low-cost solution to the challenge of open defecation. These simple, often unlined pits collect human waste but pose significant risks to environmental and public health due to potential groundwater contamination. Emerging evidence suggests that chemical pollutants from pit latrines, particularly endocrine-disrupting chemicals (EDCs), may contribute to early puberty in children, especially girls, with far-reaching health, social, and educational consequences. Early puberty, defined as pubertal development before age 8 in girls or 9 in boys, is associated with increased risks of mental health disorders, reproductive health issues, and socioeconomic challenges, particularly in resource-constrained settings. In Africa, where sanitation inf...
Read more
-
  Health insurance affordability and the quality of life among low Socioeconomic Status (SES) individuals in Low- and Middle-Income Countries (LMICs)   Preamble: Whereas the right to health is a fundamental human right, it remains inaccessible to many, especially those of low socioeconomic status (SES) in low- and middle-income countries (LMICs); and whereas the affordability of health insurance is a critical factor that can enhance or impede access to necessary healthcare services; we recognize that the ability to obtain health insurance plays a pivotal role in determining the quality of life for individuals and families within these communities. Acknowledging that the lack of affordable health insurance options leads to a disproportionate burden of disease and financial hardship on low SES populations; and understanding that the provision of affordable health insurance is not only a matter of social justice but also an investment in the social and economic development ...
Read more
-
Child Health:  Dealing with Aflatoxins in Children’s Food Aflatoxins, produced primarily by Aspergillus flavus and A. parasiticus , are highly toxic and carcinogenic mycotoxins that contaminate key food crops in tropical and subtropical regions. In low- and middle-income countries (LMICs), especially across sub-Saharan Africa, chronic exposure to aflatoxins in staple foods poses grave health risks for children, including growth impairment, immunosuppression, developmental deficits, and increased vulnerability to infectious diseases. This paper explores the sources of aflatoxin contamination in children's food, its public health impacts, and proposes multisectoral policies and interventions to protect child health and nutrition, with a focus on evidence from Africa. 1. Introduction Aflatoxin contamination is one of the most pressing yet under-addressed food safety challenges affecting children in LMICs. Staple foods such as maize, sorghum, groundnuts, and dairy products are pro...
Read more